These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 18286988)

  • 1. Pharmacy program with DM component targets CKD.
    Dis Manag Advis; 2008 Jan; 14(1):8-10, 1. PubMed ID: 18286988
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disease management in chronic kidney disease.
    Rastogi A; Linden A; Nissenson AR
    Adv Chronic Kidney Dis; 2008 Jan; 15(1):19-28. PubMed ID: 18155106
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Building the chronic kidney disease management team.
    Spry L
    Adv Chronic Kidney Dis; 2008 Jan; 15(1):29-36. PubMed ID: 18155107
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Healthcare costs associated with nephrology care in pre-dialysis chronic kidney disease patients.
    Vekeman F; Yameogo ND; Lefebvre P; Bailey RA; McKenzie RS; Piech CT
    J Med Econ; 2010; 13(4):673-80. PubMed ID: 21050062
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Costs of managing anemia with erythropoiesis-stimulating agents during hemodialysis: a time and motion study.
    Schiller B; Doss S; DE Cock E; Del Aguila MA; Nissenson AR
    Hemodial Int; 2008 Oct; 12(4):441-9. PubMed ID: 19090867
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current status of chronic kidney disease care in southeast Asia.
    Jha V
    Semin Nephrol; 2009 Sep; 29(5):487-96. PubMed ID: 19751894
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diabetes, kidney disease and cardiovascular disease patients. Assessing care of complex patients using outpatient testing and visits: additional metrics by which to evaluate health care system functioning.
    Levin A; Chaudhry MR; Djurdjev O; Beaulieu M; Komenda P
    Nephrol Dial Transplant; 2009 Sep; 24(9):2714-20. PubMed ID: 19395415
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Disease management improves outcomes in patients with CKD.
    Nissenson AR
    Nephrol News Issues; 2003 Aug; 17(9):15-9. PubMed ID: 12971220
    [No Abstract]   [Full Text] [Related]  

  • 9. The effect of new pharmaceutical agents on pharmacy budgets.
    Kozma CM
    Manag Care Interface; 1999 Jan; 12(1):77-8. PubMed ID: 10345243
    [No Abstract]   [Full Text] [Related]  

  • 10. Disease management programs for CKD patients: the potential and pitfalls.
    Rocco MV
    Am J Kidney Dis; 2009 Mar; 53(3 Suppl 3):S56-63. PubMed ID: 19231762
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The first ESRD managed care demonstration project: a Kaiser Permanente view.
    Crooks P
    Nephrol News Issues; 2003 Oct; 17(11):29-31, 34-5. PubMed ID: 14593817
    [No Abstract]   [Full Text] [Related]  

  • 12. ESRD management program cuts hospital utilization by 35 percent.
    Rollins G
    Rep Med Guidel Outcomes Res; 2001 Mar; 12(6):10, 12. PubMed ID: 12053944
    [No Abstract]   [Full Text] [Related]  

  • 13. Specialty pharmacy's true out-of-pocket costs.
    Manag Care; 2009 Dec; 18(12):54. PubMed ID: 20088150
    [No Abstract]   [Full Text] [Related]  

  • 14. Effect of chronic kidney disease on individual and population medical expenditures in the Japanese population.
    Higashiyama A; Okamura T; Watanabe M; Murakami Y; Otsuki H; Adachi N; Kaneko C; Uehara E; Okayama A; Ueshima H
    Hypertens Res; 2009 Jun; 32(6):450-4. PubMed ID: 19373238
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Screening populations at increased risk of CKD: the Kidney Early Evaluation Program (KEEP) and the public health problem.
    Vassalotti JA; Li S; Chen SC; Collins AJ
    Am J Kidney Dis; 2009 Mar; 53(3 Suppl 3):S107-14. PubMed ID: 19231754
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Renal care organizations back new CKD initiative.
    Neumann ME
    Nephrol News Issues; 2003 Feb; 17(3):17, 19. PubMed ID: 12655990
    [No Abstract]   [Full Text] [Related]  

  • 17. The drug add-on component--have all provider types seen budget neutrality?
    Mentz K
    Nephrol News Issues; 2005 Sep; 19(10):42-4. PubMed ID: 16187646
    [No Abstract]   [Full Text] [Related]  

  • 18. The new ESRD. Demonstration project on disease management.
    Jones ER
    Nephrol News Issues; 2003 Oct; 17(11):25-8. PubMed ID: 14593816
    [No Abstract]   [Full Text] [Related]  

  • 19. Methodological considerations for end-of-life research in patients with chronic kidney disease.
    Davidson SN; Murtagh FE; Higginson IJ
    J Nephrol; 2008; 21(3):268-82. PubMed ID: 18587713
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CKD screening and management in the Veterans Health Administration: the impact of system organization and an innovative electronic record.
    Patel TG; Pogach LM; Barth RH
    Am J Kidney Dis; 2009 Mar; 53(3 Suppl 3):S78-85. PubMed ID: 19231765
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.